Publications

Dupilumab long-term efficacy in patients with asthma with or without comorbid chronic rhinosinusitis/nasal polyposis enrolled in LIBERTY ASTHMA TRAVERSE from phase 2b study

Publié en January 2022 ALLERGOLOGIE
January 2022

Pathophysiology of severe asthma : What are the molecular targets for biotherapies?

ALLERGOLOGIE
Previous publication
January 2022

Dupilumab long-term efficacy in patients with asthma with or without comorbid chronic rhinosinusitis/nasal polyposis enrolled in LIBERTY ASTHMA TRAVERSE from phase 2b study

ALLERGOLOGIE
Next publication

Authors